Takara Bio USA, Inc RetroNectin® GMP grade reagent
ID: 24-002687Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/b3b91922ab37470b913796e67f343fd0/view
Timeline
  1. 1
    Posted Dec 13, 2023 2:38 PM
  2. 2
    Updated Dec 13, 2023 2:38 PM
  3. 3
    Due Dec 23, 2023 5:00 PM
Description

Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is planning to procure Takara Bio USA, Inc RetroNectin® GMP grade reagent. This reagent is typically used in the development, evaluation, and validation of investigational new drugs (INDs) for cellular therapies and the manufacture of cellular therapy products for approved clinical trials. The Center of Cellular Engineering, an AABB accredited cellular therapy laboratory, intends to purchase 30 vials of RetroNectin® GMP grade reagent from Takara Bio USA, Inc. The reagent will be used in the manufacturing process of clinical T-cells for the treatment of NIH CC patients with various medical conditions. The acquisition will be conducted using simplified acquisition procedures, and interested parties may submit their capabilities and interest in response to this notice. The closing date for submissions is December 23, 2023, at 12:00 pm EST.

Point(s) of Contact
Sheri Eiri
000000000
sheri.eiri@nih.gov
Files
No associated files provided.
Lifecycle
Title
Type
Takara Bio USA, Inc RetroNectin® GMP grade reagent
Currently viewing
Presolicitation
Similar Opportunities
ROCHE DISCOVERY REAGENTS (AMBIS 2232206)
Active
Health And Human Services, Department Of
The Department of Health and Human Services, National Institutes of Health, is seeking Roche Discovery Reagents through a Combined Synopsis/Solicitation notice. These reagents are used for lab experiments and maintaining continuity of results. They are ready-to-use research reagents designed for immunohistochemistry (IHC) and in situ hybridization (ISH) with the DISCOVERY ULTRA and DISCOVERY XT instruments. The purpose of this procurement is to support the research and research training programs of the National Institute of Allergy and Infectious Diseases (NIAID) in finding causes, improved methods, and prevention of immunologic and infectious diseases. The procurement includes specific items and quantities, such as DISCOVERY OmniMap anti-Rb HRP RUO (Qty - 6) and DISCOVERY Purple Kit RUO (Qty - 15), along with shipping and handling. The place of performance is in Hamilton, Montana, United States. The procurement will be awarded based on technical capability and price. Interested vendors must submit their quotes through the NIAID e-BidBoard System by August 2, 2024, at 4:00 PM EST. For more information, contact Rita Davis at rita.davis@nih.gov.
Notice of Intent to Sole Source – R&D Systems
Active
Health And Human Services, Department Of
Notice of Intent to Sole Source – R&D Systems The Department of Health and Human Services, Department of, National Institutes of Health, intends to award a fixed price purchase order to Bio-Techne for Bio-techne kits used for molecular profiling of histological samples following high intensity focused ultrasound (HIFU) at the National Institutes of Health (NIH) Clinical Center (CC) Department of Radiology & Imaging Sciences (RADIS). These kits are used for biological product manufacturing and fall under the category of laboratory equipment and supplies. The procurement will take place in Bethesda, Maryland, United States. The proposed vendor, BioTechne, is the only source available to provide the kits with the required specifications needed by the NIH CC RADIS department. This acquisition is being conducted using simplified acquisition procedures and is not open for competition. Interested parties may submit their capabilities and interest in response to this notice. The closing date for submissions is August 1st, 2024 at 2pm EST. For more information, contact Kristin Nagashima, Contract Specialist at kristin.nagashima@nih.gov.
65--Single Cell RNA Sequencing Kits for NICHD Thyroid
Active
Health And Human Services, Department Of
The National Institutes of Health, National Institute of Child Health and Development (NICHD) plans to award a contract for Single Cell RNA Sequencing Kits to support thyroid hormone studies. This is a pre-solicitation notice, with the intent to award the contract without competition to 10X GENOMICS, INC. The NICHD invites capable and interested parties to submit responses outlining their qualifications and capacity to fulfill the requirement. The agency will consider the information received but maintains discretion on whether to proceed competitively or non-competitively. The opportunity seeks to procure single-cell RNA sequencing kits for research purposes. Respondents should have the capability to provide the required sequencing kits and ensure compliance with the specialized needs of thyroid hormone studies. To participate, interested parties must register in the System for Award Management (SAM) and submit their responses by the deadline. The primary contact for this opportunity is Jacob Balenson, whose email is provided in the listing. Please note that responses must be submitted electronically, following the specified format and deadline.
10X GENOMICS KITS REAGENTS (AMBIS 2230829)
Active
Health And Human Services, Department Of
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking to procure 10X Genomics Kits Reagents. These kits are typically used for studying the systems biology of the host immune response to vector-borne pathogens on a global scale, and at single-cell resolution. The kits allow for transcriptional and cell surface protein profiling of tens of thousands of single cells in parallel, providing high-resolution insights into gene expression and cellular function. The procurement is a combined synopsis/solicitation for commercial items, with a total small business set-aside. The place of performance is Rockville, Maryland, and the delivery estimate is 45 days after receipt of order. Interested vendors must submit their quotes through the NIAID electronic Simplified Acquisition Submission System (eSASS) website. The deadline for submission is July 29, 2024, at 4:00 PM EST.
THERAKOS CELLEX Photopheresis System Procedural Kits
Active
Health And Human Services, Department Of
Presolicitation HEALTH AND HUMAN SERVICES, DEPARTMENT OF is planning to procure THERAKOS CELLEX Photopheresis System Procedural Kits. These kits are typically used for extracorporeal photopheresis therapy to patients post stem-cell transplantation on the existing government owned THERAKOS CELLEX Photopheresis System Instrument. The procurement will be a one-time fixed price contract awarded to Therakos Inc. on a sole source basis. The kits are required for emergent Extracorporeal Photopheresis (ECP) procedures for Clinical Center patients in Bethesda, Maryland. The acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures. Interested parties capable of providing the same or similar products may submit a capability statement for consideration. Comments can be submitted to the Office of Purchasing and Contracts until July 29, 2024.